简体中文 | 繁體中文 | English

Products & Services News

2024-12-19 10:33 Interactive Brokers Enhances IBKR Desktop Trading Platform with New Tools and Features
2024-12-19 10:23 Novotech Publishes Report on the Global COVID-19 Clinical Trial Landscape, Highlighting Key Trends, Therapeutic Advancements, and Challenges in Drug Development
2024-12-19 10:15 Novotech Releases Report on Global Parkinson’s Disease Clinical Trial Landscape
2024-12-19 10:08 ESI Group and China Automotive Engineering Research Institute Co., Ltd. join forces on Intelligent Simulation
2024-12-18 16:28 InEight and Project Control Academy Team Up to Advance Project Controls Best Practices
2024-12-18 16:17 Falcon 3: UAE’s Technology Innovation Institute Launches World’s Most Powerful Small AI Models That Can Also be Run on Light Infrastructures, Including Laptops
2024-12-18 11:14 AIT Worldwide Logistics Secures ISO Quality, Safety, and Sustainability Certifications Across Asia
2024-12-18 10:26 SES’s Seventh and Eighth O3b mPOWER Satellites Successfully Launched, Bolstering MEO Constellation
2024-12-18 10:18 Biocodex Strengthens Supply Chain Resilience with Kinaxis
2024-12-18 09:07 Newline Group Opens New Office in Hong Kong
2024-12-18 09:04 Hong Kong (HKG) to Taipei (TPE) is the World’s Busiest International Airline Route in 2024, Latest OAG Data Reveals
2024-12-17 19:16 Japan Fruit and Vegetables Export Promotion Council: Smile Japanese Fruits Gift Campaign
2024-12-17 16:11 HistoSonics Edison® Histotripsy System Treats First Pancreatic Tumor Patients in GANNON Trial
2024-12-17 10:53 Humanetics Publishes Groundbreaking Data on the Growth of the Chinese Population
2024-12-17 10:17 ONE Development Announces Strategic Collaboration with The Legend Amr Diab as Brand Ambassador
2024-12-17 10:10 Biocytogen Announces Adcendo ApS Exercises Antibody Option to Accelerate ADC Development
2024-12-16 15:51 Celltrion Receives Positive CHMP Opinion for Three Biosimilars in the European Union
2024-12-16 10:42 Galderma Receives U.S. FDA Approval for Nemluvio® (Nemolizumab) for Patients with Moderate-to-Severe Atopic Dermatitis
2024-12-16 10:29 Experian’s 2024 Global Identity & Fraud Report Spotlights Huge Growth in Highly Personalized GenAI-Driven Fraud Attacks
2024-12-16 10:26 BrightPath Bio and Cellistic Announces Process Development and Manufacturing Collaboration for Phase 1 Clinical Trial of iPSC-derived BCMA CAR-iNKT cell

Business Wire Weibo

Press Releases

Latest Releases